Bio-fabricated corneal transplant
Pre-clinical- Indications
- Corneal blindness, Endothelial keratoplasty
Company intelligence / Profile preview
Precise Bio has developed a proprietary platform for scalable production of transplantable tissues and organs using advanced single-cell resolution bioprinting. Its lead program focuses on bio-fabricated human corneas for ophthalmic use. The company has demonstrated proof-of-concept in preclinical models but has not yet reported late-stage clinical results or commercial launches.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Precise Bio.